Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mycophenolate mofetil in solid-organ transplantation.

Titte R Srinivas1, Bruce Kaplan, Herwig Ulf Meier-Kriesche

  • 1Division of Nephrology, Hypertension and Transplantation, University of Florida, 1600 SW Archer Road, Box 100224, Gainesville, FL 32610-0224, USA.

Expert Opinion on Pharmacotherapy
|December 4, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex-based survival disparities persist in liver transplantation: MELD 3.0 fails to improve survival for waitlisted women.

Frontiers in transplantation·2026
Same author

Recipient Social Determinants and Geographic Access in DCD Liver Transplantation: Early Lessons During the Perfusion era.

Transplantation·2026
Same author

Social Determinants of Health Impact COVID-19-Related Mortality Among Liver Transplant Recipients in the United States.

Transplant infectious disease : an official journal of the Transplantation Society·2025
Same author

Managing Expectations of Prolonged Warm Ischemia Time: A Calculator to Predict Donation After Circulatory Death Donor Progression to Circulatory Death Within 30 Min.

Clinical transplantation·2025
Same author

Cognitive Impairment in CMV Seropositive and CMV Seronegative Deceased Donor Kidney Transplant Recipients.

Transplantation direct·2025
Same author

Hidden Markov Models Offer a Powerful Approach for Understanding Gene Regulation Mechanisms Relevant for Organ Transplantation.

Transplantation·2025

Mycophenolate mofetil (MMF) effectively suppresses the immune system by inhibiting lymphocyte proliferation, crucial for solid-organ transplantation success. This review details MMF

Area of Science:

  • Immunology
  • Pharmacology
  • Transplantation Medicine

Background:

  • Mycophenolate mofetil (MMF) is a key immunosuppressant in solid-organ transplantation.
  • It functions by inhibiting inosine monophosphate dehydrogenase (IMPDH), crucial for purine synthesis in lymphocytes.
  • MMF selectively inhibits T and B lymphocyte proliferation and may induce apoptosis.

Purpose of the Study:

  • To review the role and mechanisms of MMF in solid-organ transplantation.
  • To discuss MMF's pharmacokinetics, pharmacodynamics, and therapeutic drug monitoring.
  • To summarize clinical trial outcomes and specific applications in renal transplantation.

Main Methods:

  • Review of existing literature on MMF in solid-organ transplantation.
  • Analysis of pivotal clinical trials in kidney and heart transplantation.

Related Experiment Videos

  • Discussion of MMF's effects on lymphocyte proliferation, antibody synthesis, and inflammatory pathways.

    • Main Results:

    • MMF demonstrates significant immunosuppressive effects primarily through IMPDH inhibition.
    • Clinical trials confirm MMF's positive impact on renal transplantation outcomes.
    • MMF exhibits additional effects including smooth muscle cell proliferation inhibition and anti-inflammatory properties.

    Conclusions:

    • MMF is a vital immunosuppressant in solid-organ transplantation, offering selective lymphocyte inhibition.
    • Its efficacy is well-established in renal transplantation, with benefits in complex cases.
    • Understanding MMF's mechanisms and monitoring is essential for optimizing patient outcomes.